Potential Protein Biomarkers for Preeclampsia.

Area of Science:

• Biochemistry
• Medical Science
• Genomics

Background:

• Preeclampsia (PE) etiology remains unclear, necessitating improved prediction and prevention strategies.
• Current treatments for PE are limited, highlighting the need for early diagnostic tools.
• Proteomics offers a powerful approach to discover biomarkers associated with PE.

Purpose of the Study:

• To review the application of proteomics in preeclampsia research.
• To identify potential protein biomarkers for PE prediction.
• To enhance understanding of PE's pathological mechanisms.

Main Methods:

• Literature review of proteomics studies in preeclampsia.
• Analysis of identified protein biomarkers.
• Synthesis of findings to guide future research.

Main Results:

• Proteomics has identified numerous potential protein biomarkers for PE.
• These biomarkers aid in predicting PE onset and understanding its pathology.
• The review consolidates current knowledge on proteomics in PE.

Conclusions:

• Proteomics is instrumental in advancing preeclampsia biomarker discovery.
• Further research is needed to validate these biomarkers for clinical application.
• Understanding protein changes can lead to better PE management.